Baystreet Staff - Friday, January 8, 2016 Acasti Pharma Inc. 09:47 AM EST - Acasti Pharma Inc. : Has entered into a transactional arrangement and signed operational agreements with its parent company, Neptune Technologies and Bioressources Inc. Acasti Pharma Inc. shares V.APO are trading unchanged at $2.94.